Invesco
MIST icon

Invesco’s Milestone Pharmaceuticals MIST Stock Holding History

Invesco’s Portfolio MIST Stock Details MIST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-41,356
Closed -$49.2K – 3898
2026
Q1 		$49.2K Buy
41,356
+19,463
+89% +$34.1K ﹤0.01% 3695
2025
Q4 		$44.2K Buy
+21,893
New +$47.2K ﹤0.01% 3718
2020
Q4 		– Sell
-315,404
Closed -$2.31M – 3801
2020
Q3 		$2.31M Sell
315,404
-4,973
-2% -$35.6K ﹤0.01% 2419
2020
Q2 		$1.21M Hold
320,377
– – ﹤0.01% 2712
2020
Q1 		$589K Sell
320,377
-2,056
-0.6% -$35.6K ﹤0.01% 2987
2019
Q4 		$5.16M Sell
322,433
-2,567
-0.8% -$45.4K ﹤0.01% 2145
2019
Q3 		$6.06M Hold
325,000
– – ﹤0.01% 2022
2019
Q2 		$8.82M Buy
+325,000
New +$6.7M ﹤0.01% 1829

Other funds holding MIST

PCM
Pavaki Capital Management Pueblo, Colorado $287M AUM
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
PBM
Propel Bio Management Los Angeles, California $191M AUM 102.42% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
SAM
Simplify Asset Management Las Vegas, Nevada $7.19B AUM 6.88% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
KCM
Kalehua Capital Management Dallas, Texas $174M AUM
LPC
Lion Point Capital New York $20.9M AUM 195.52% 1-Year Est. Return

Invesco's MIST Position: Q2 2026 in Review

Invesco sold out of Milestone Pharmaceuticals (MIST) in Q2 2026, closing a stake of 41,356 shares — an estimated $49.2K sold.

Invesco first reported a position in MIST in Q2 2019 and held it in 8 quarters. The position peaked at $8.82M in Q2 2019. 78 funds tracked by Wall St. Rank hold MIST as of Q2 2026.

  • Invesco reported no remaining Milestone Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
  • Invesco sold 41,356 Milestone Pharmaceuticals shares in Q2 2026, an estimated $49.2K.
  • Invesco first reported a position in Milestone Pharmaceuticals in Q2 2019 and held it in 8 quarters.
  • Invesco's Milestone Pharmaceuticals position peaked at $8.82M in Q2 2019.
  • 78 funds tracked by Wall St. Rank held Milestone Pharmaceuticals as of Q2 2026.

Based on Invesco's 13F filing for Q2 2026, filed 14 Aug 2026.